Tenderwize
Back to tender search

Eltrombopag rebate agreement

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Aug 03, 2027 · 351 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Eltrombopag, ausgeschl. Anwendungsgebiet schwere aplastische Anämie in der Fachinformation, es sei denn, der Hersteller genießt hierfür Patenschutz, ATC B02BX05

46/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

46 / 100

Complexity

58 / 100

Risk factors

The notice explicitly says the contract documents must be submitted via the communication area of the DTVP portal and n...

The final contract-conclusion deadline is 03.08.2027, and monthly cut-offs apply for next-month starts; missing the cut...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Sep 2027
  • Non-exclusive open-house rebate agreements for the medicinal product Eltrombopag (ATC B02BX05).
  • Exclusion of the severe aplastic anemia indication in the product information, unless the manufacturer has patent protection for that indication.
Show full summary

Open-house supply arrangement for pharmaceutical products: non-exclusive rebate agreements for Eltrombopag (ATC B02BX05), excluding the severe aplastic anemia indication unless the manufacturer has patent protection for that indication. The contracting buyer is AOK Bayern. This is explicitly described as a non-competitive open-house model with no selection of one or more bidders; any pharmaceutical company meeting the stated suitability requirement may join on identical, non-negotiable terms. Contracting is possible until 03.08.2027, with monthly start dates depending on when complete documents are received. Procurement documents are available via DTVP, but only the notice text was analyzed, not the full document set.

Risks

The notice explicitly says the contract documents must be submitted via the communication area of the DTVP portal and n...

The final contract-conclusion deadline is 03.08.2027, and monthly cut-offs apply for next-month starts; missing the cut...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • The contract and the annex 'Festlegung der vertragsgegenständlichen Arzneimittel' must be completed and signed.

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • A signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Eltrombopag rebate agreement

Open-house rebate agreement for Eltrombopag, excluding the severe aplastic anemia indication in the product information unless the manufacturer has patent protection for that indication. Scope is supplies of pharmaceutical products under a non-exclusive, identical, non-negotiable rebate contract. The lot information comes from structured data and notice text.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Sep 2025 - Sep 2027

Category

Pharmaceutical products

Deadline

Deadline Aug 03, 2027

Procurement Details

Publication date
13 Aug 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
533121-2025

Documents (2)

Similar tenders